If you’d like to learn more about the practical applications of in vitro inhalation toxicity assessment, you can schedule a call with Louis Scott who will be able to share use cases for similar organisations to yours.
Prof. Victoria Hutter
Chief Scientific Officer
Victoria spent 8 years at the University of Hertfordshire from lecturer to associate professor and established her own independent research team; securing over £6M funding in topical drug delivery and toxicology. This supported the development of new innovations and IP in novel human cell culture models and techniques as alternatives to animal testing.
Dr Victoria Hunter co-founded ImmuONE in 2019 with Abigail Martin after a successful ‘Innovation to Commercialisation of University Research’ (ICURe) programme which allowed us to accelerate our human in vitro immunocompetent lung models to market. Her role as Chief Scientific Officer spans the scientific and commercial aspects of the company.
Dr Louis Scott
Client Relations Manager
Louis is a true believer in the need for robust, animal-free, and human-relevant models in toxicity testing and is an immunologist by trade.
“Exploring the modulation of macrophage biology in commercial testing is pivotal for understanding important aspects of how lungs and bodies are affected by inhaled compounds.
Immune cells are our knights in shining armour when it comes to protecting our body, and by that logic, ensuring their health is incredibly important.”
You can arrange a call with Louis and explore how morph_ONE can speed up and improve the accuracy of your macrophage testing.
